You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (14)

Journals (0)

1-10 of 14 results for dual HER2 blockade

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab

Open access

Research article

First published 2021

Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab

Elisabeth Sophie Bergen, Amelie Binter, Angelika Martina Starzer [...]

Therapeutic Advances in Medical Oncology

Select article: Dual HER2 Blockade in Neoadjuvant Treatment of HER2+ Breast Cancer: A Meta-Analysis and Review

Open access

Research article

First published 2020

Dual HER2 Blockade in Neoadjuvant Treatment of HER2+ Breast Cancer: A Meta-Analysis and Review

Chaokun Wang, Jing Chen, Xiangyun Xu [...]

Technology in Cancer Research & Treatment

Select article: Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade

Retricted access

Case report

First published 2019-9

Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade

Omer Fatih Olmez, Oguzcan Kinikoglu, Nesrin Helvacı Yilmaz [...]

Journal of Oncology Pharmacy Practice

Select article: First-Line Treatment of HER2-Positive Metastatic Breast Cancer With Dual Blockade Including Biosimilar Trastuzumab (SB3): Population-Based Real-World Data From the DBCG

Open access

Research article

First published 2022

First-Line Treatment of HER2-Positive Metastatic Breast Cancer With Dual Blockade Including Biosimilar Trastuzumab (SB3): Population-Based Real-World Data From the DBCG

Alan Celik, Tobias Berg, Lise Birk Nielsen [...]

Breast Cancer: Basic and Clinical Research

Select article: Neoadjuvant therapy of early stage human epidermal growth factor receptor 2 positive breast cancer: latest evidence and clinical implications

Free access

Review article

First published 2014-9

Neoadjuvant therapy of early stage human epidermal growth factor receptor 2 positive breast cancer: latest evidence and clinical implications

Sonia Pernas Simon

Therapeutic Advances in Medical Oncology

Select article: Efficacy and Safety of Dual Anti-HER2 Blockade and Docetaxel With or Without Carboplatin as Neoadjuvant Regimen for Treatment of HER2-Positive Breast Cancer

Open access

Research article

First published 2023

Efficacy and Safety of Dual Anti-HER2 Blockade and Docetaxel With or Without Carboplatin as Neoadjuvant Regimen for Treatment of HER2-Positive Breast Cancer

Binwei Lin, Jinjia Fan, Fang Liu [...]

Technology in Cancer Research & Treatment

Select article: Evolving perspectives on the treatment of HR+/HER2+ metastatic breast cancer

Open access

Review article

First published 2023

Evolving perspectives on the treatment of HR+/HER2+ metastatic breast cancer

Mark Pegram, Richard Pietras, Chau T. Dang [...]

Therapeutic Advances in Medical Oncology

Select article: HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance

Open access

Review article

First published 2019

HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance

Sonia Pernas, Sara M. Tolaney

Therapeutic Advances in Medical Oncology

Select article: Anthracycline-containing versus carboplatin-containing neoadjuvant chemotherapy in combination with trastuzumab for HER2-positive breast cancer: the neoCARH phase II randomized clinical trial

Open access

Research article

First published 2021

Anthracycline-containing versus carboplatin-containing neoadjuvant chemotherapy in combination with trastuzumab for HER2-positive breast cancer: the neoCARH phase II randomized clinical trial

Hong-Fei Gao, Zhiyong Wu, Ying Lin [...]

Therapeutic Advances in Medical Oncology

Select article: Resistance to therapy in estrogen receptor positive and human epidermal growth factor 2 positive breast cancers: progress with latest therapeutic strategies

Free access

Review article

First published 2016-11

Resistance to therapy in estrogen receptor positive and human epidermal growth factor 2 positive breast cancers: progress with latest therapeutic strategies

Laurence Lousberg, Joëlle Collignon, Guy Jerusalem

Therapeutic Advances in Medical Oncology

1
2
10 / page

Article type

Publication date

Subjects

Access